schools will not offer remote option this fall, in a major push to get the city s 1 million students back in the classroom. school officials say students need to wear masks and follow other cdc guidelines. joining us, founder and ceo f advancing health equity and msnbc contributor. great to have you back on the program. the reporting on the wuhan lab researchers getting sick, does that add weight to the motion that coronavirus could have escaped from the lab? okay. so what the news tells us is that we need more information, we need a more thorough investigation and gives us more questions, questions that i have are what are the lab protocols, what are their safety and sick plans. we need to see log books for workers. we don t know what their diagnosis was. we know they had covid-like
An update on Lab and Study Protocols at PLOS ONE
Emily Chenette, Editor-in-Chief, PLOS ONE
PLOS empowers researchers to transform science by offering more options for credit, transparency and choice. The launch of Lab Protocols and Study Protocols in
PLOS ONE earlier this year supported this crucial goal by bringing reproducibility and transparency to research, and enabling those who contributed to study design to receive credit for their contributions.
Today, we’re delighted to share the news that two Study Protocols have now been published in
PLOS ONE.
The first, by Satoru Joshita and colleagues, describes a protocol for studying the prevalence and etiology of portopulmonary hypertension in a cohort of Japanese people with chronic liver disease.
Registered Reports: One Year at PLOS ONE plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.
A new Editor-in-Chief for PLOS ONE
PLOS ONE community,
What a joy it is to write this letter – to have the opportunity to reflect on the strengths of
PLOS ONE and consider how we can best meet your needs in the years ahead. I’m writing to you to share what you can expect from me as Editor-in-Chief of
PLOS ONE, and to call for your feedback and your perspective on what we’ve gotten right, and where we can improve.
I am a molecular biologist by training. I received my PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill in 2004, and studied gene expression signatures in lung cancer cells while a postdoc at Duke University. As a brand-new postdoc I had the experience that I am sure will be familiar to many of you of writing grants to secure funding for my research – and I realised, during this process, that what I really loved about scientific research was not the process of making the discoveries myself, but reading papers and consid